Fulcrum Equity Partners: Investment Strategy, Funds, Portfolio Companies, and Firm Profile
Fulcrum Equity Partners is included in the Umbrex Top 1000 Global Private Equity Firms research collection. “Top 1000” identifies the collection, not a verified ranking or an endorsement of investment performance, fundraising strength, or suitability for a particular business.
1. What Is Fulcrum Equity Partners?
Fulcrum Equity Partners is an Atlanta-based growth equity firm investing in business-to-business software and healthcare services. Its public operating history is measured from 2006, although its predecessor investment activity began earlier. Frank X. Dalton, Tom Greer, and Jeff Muir are identified as founders of the fund-based organization; Alston Gardner’s founding role is also connected to its predecessor, Fulcrum Ventures.
The firm makes both minority and majority growth investments rather than requiring control in every transaction. Its proposition combines equity capital with operating experience and support for management teams. Software financings and healthcare partnerships demonstrate this flexible ownership model.
For directory purposes, Fulcrum fits Growth equity / venture crossover, with Sector-specialist private equity as a complementary editorial description. The United States is its principal market in this profile, and North America is the appropriate geography group. These classifications describe the reviewed investment model and geographic footprint, not investment quality or a promise of future activity.
2. Fulcrum Equity Partners at a Glance
- Firm name
- Fulcrum Equity Partners.
- Firm type
- Growth equity firm investing in private operating businesses.
- Founded
- 2006 is the firm’s public operating reference; predecessor investing and earlier partner activity are discussed below.
- Founders
- Frank X. Dalton, Tom Greer, and Jeff Muir; Alston Gardner is also identified as a co-founder and founded predecessor Fulcrum Ventures.
- Headquarters
- Atlanta, Georgia, United States. The original formation city was not separately established in this review.
- Parent organization
- A corporate parent was not verified. Fulcrum Ventures is described as a predecessor, not as a current parent.
- Main investment markets
- United States, based on the reviewed investment footprint.
- Geography group
- North America, an editorial classification.
- Directory segments
- Growth equity / venture crossover; Sector-specialist private equity.
- Principal strategies
- Growth financing, expansion capital, acquisitions, and shareholder liquidity.
- Ownership preference
- Minority and majority investments.
- Typical company profile
- Revenue-generating software businesses and growing healthcare service platforms.
- Sector focus
- B2B software, healthcare services, and healthcare information technology.
- Current major identifiable funds
- Fund V; Fund IV remains associated with selected continuing investments.
- Current status
- Operating, with investment activity documented in 2026.
- Official website
- Fulcrum Equity Partners Official Website
3. Who Founded Fulcrum Equity Partners, and How Is the Firm Organized?
Fulcrum’s history has two related layers: an earlier investment operation associated with Jeff Muir and Alston Gardner, and the subsequent fund-based firm associated with Muir, Frank X. Dalton, and Tom Greer. Gardner’s biography describes him as founder and managing partner of Fulcrum Ventures, the predecessor to Fulcrum Equity Partners, and identifies him as a co-founder and operating partner.
The early dates require care. Muir dates the initial personal-capital investing activity to 2000, following the sale of OnTarget to Siebel Systems. Gardner’s biography dates Fulcrum Ventures to 2001. Dalton’s role history begins in 2005, while the firm’s homepage measures its activity from 2006. These dates should not be collapsed into a single incorporation or first-fund date. Atlanta is the verified headquarters; the original formation city was not separately verified.
The founders brought different operating backgrounds. Muir had been OnTarget’s chief operating officer, Greer founded and led Regency Healthcare Group, and Dalton held financial, operating, and investment roles before Fulcrum. Jim Douglass and Philip Lewis are identified as partners in 2026 investment announcements. The organization also publicly identifies operating partners and describes access to service partners and an executive network.
The reviewed evidence does not establish a complete current management-company ownership breakdown. Accordingly, founder roles, investment-partner roles, and fund investors are kept distinct.
4. What Is the History of Fulcrum Equity Partners?
Fulcrum developed from investing capital associated with entrepreneurs into a recurring growth-fund organization. Its history is best understood through the formation of that fund franchise, successive capital raises, and the development of repeat relationships with operating businesses. Muir describes the original approach as investing personal capital and money from partners, friends, and family before formalizing the activity into a fund.
- Early origins: Fulcrum Ventures preceded the current firm. Its history is associated with Gardner and Muir and their experience at OnTarget. The public biographies use 2000 and 2001 for different descriptions of these beginnings.
- 2006: The first Fulcrum fund was raised with $40 million of capital. This is consistent with the current firm’s public “since 2006” operating reference.
- January 2013: The second fund closed with $93 million of capital commitments, extending the sequential growth-fund model.
- July 2017: Fulcrum Growth Fund III reached a final close with $203 million of committed capital. The accompanying account described support from existing entrepreneur investors and additional institutions.
- March 2021: Fund IV closed with $275 million of committed capital. Its investor base included institutions, family offices, and current or former business owners and CEOs.
- 2024 onward: Fund V’s final close continued the software and healthcare strategy. Subsequent documented activity includes MedScout’s February 2026 growth round and Worth’s March 2026 Series A financing.
Individual company histories also show continuity across funds. Summit Spine & Joint Centers moved from an original Fund III investment into a subsequent Fund IV relationship in 2021 before Fulcrum’s reported firm-level exit in 2025. That sequence illustrates why a transaction described as a “sale” can end one fund’s holding without immediately ending the firm’s investment exposure.
5. What Investment Strategies Does Fulcrum Equity Partners Pursue?
Fulcrum pursues growth equity in B2B software and healthcare services, with flexibility to take minority or majority positions. Its published equity-investment range is $5 million to $35 million. This is an equity-capital parameter, not a target enterprise-value range, company revenue range, or total financing-round size.
The software activity overlaps with venture financing terminology without making Fulcrum exclusively a venture capital investor. MedScout’s investment was structured as a Series A round, Reflectiz’s financing as a Series B, and Kevel’s later financing as a Series C. These are investments in operating software businesses, alongside the firm’s healthcare service-platform activity.
The ownership model is similarly flexible. Pediatrics Plus’s partnership brought Fulcrum together with Leavitt Equity Partners and Western Governors University, while the founders remained the largest shareholders at the transaction announcement. That example demonstrates a partnership model that does not require Fulcrum to become the sole owner. It does not establish an unchanged ownership percentage today.
Fund V’s stated uses of capital include faster growth, tuck-in acquisitions, and shareholder liquidity over an investment’s lifecycle. The firm describes an engaged relationship with management that balances input and autonomy. Analytically, this places Fulcrum between minority expansion financing and growth-oriented control investing, rather than within a control-only buyout model.
The primary directory classification, Growth equity / venture crossover, captures that combination. It should not be read as a claim that every investment is early-stage, venture-like, majority-owned, or financed through the same transaction structure.
6. What Funds Does Fulcrum Equity Partners Manage?
Fulcrum’s publicly identifiable fund franchise comprises sequential growth funds. Its portfolio taxonomy distinguishes Funds I through V and assigns individual businesses to those funds. This profile uses those business labels without assuming that a portfolio card identifies every legal parallel vehicle, feeder, co-investment arrangement, or current participating account.
- Fulcrum Growth Fund III
- A final close of $203 million in committed capital was reported in July 2017. This is a historical fundraising amount, not a current asset valuation.
- Fulcrum Growth Fund IV
- The fund closed with $275 million in committed capital, reported on March 25, 2021. Kevel is among the businesses currently associated with Fund IV in the firm’s portfolio disclosures.
- Fulcrum Fund V
- The March 12, 2024 announcement reported a final closing at $372 million. The original target was $300 million and the original hard cap was $350 million; the partners increased the cap to accommodate additional investors. Those target and cap figures are distinct from the completed final-close amount.
Fund V’s announcement stated that the investment strategy would continue rather than change with the larger fund. Its initial investments included Defining Wellness Centers, FieldPulse, Canvs, and SurgNet Health Partners. The firm described additional capital as supporting growth, acquisitions, and shareholder liquidity.
The reviewed fund set supports understanding Fulcrum as a growth-fund manager, not as a verified permanent-capital holding company. Separate software-only, healthcare-only, infrastructure, or credit fund franchises were not established in this review. Nor was a continuation vehicle verified for the selected portfolio. Historical fund-close amounts are not added together to manufacture a current AUM figure.
7. What Types of Companies Does Fulcrum Equity Partners Invest In?
Fulcrum publishes different company criteria for its two central sectors. For B2B software, it identifies businesses with $2 million to $15 million of annual recurring revenue and 40% or greater year-over-year growth. Its qualitative criteria include strong gross and net revenue retention, industry expertise, and team chemistry. These are the firm’s stated screening characteristics, not a guarantee that every historical or future investment falls within them.
For healthcare services, Fulcrum identifies $1 million to $15 million of EBITDA and 20% or greater year-over-year growth. It highlights multi-site businesses capable of expanding through new locations and acquisitions, with potential to add ancillary services and extend continuity of care. References to quality outcomes and cost reduction describe the firm’s investment criteria, not independently measured outcomes at every company.
The selected businesses illustrate different forms of established commercial activity. FieldPulse supplies software for managing field-service operations; Kevel provides advertising infrastructure; and Pediatrics Plus operates pediatric therapy and related services. These are materially different business models even though all can require capital and organizational development to scale.
Founder participation can remain important after investment. Pediatrics Plus’s founders continued as the largest shareholders when its partnership was announced. Conversely, Summit’s history shows an original investment followed by recapitalization and a later exit. The evidence therefore supports multiple ownership situations rather than one standardized founder-transition template.
8. Which Industries Does Fulcrum Equity Partners Focus On?
Fulcrum’s principal sector focus is B2B software and healthcare services. Within software, enterprise software and SaaS is a substantive taxonomy match: the portfolio includes products used to manage business workflows, analyze information, operate advertising systems, and assess risk. FieldPulse, Canvs AI, Kevel, and Worth demonstrate these different applications.
FieldPulse serves field-service businesses with scheduling, customer management, invoicing, and payments tools. Kevel supplies APIs for companies building advertising platforms. Canvs AI analyzes open-ended feedback, while Worth addresses onboarding and underwriting workflows for financial institutions. These examples indicate breadth within B2B software rather than a single end-customer vertical.
Healthcare information technology connects the firm’s technology and healthcare interests. MedScout combines medical-claims intelligence with commercial workflow tools for medtech and life-sciences businesses. The historical Stratasan investment involved healthcare market intelligence and strategic-planning software.
Healthcare services exposure is distinct from software exposure. Pediatrics Plus provides pediatric therapy, Summit’s business centers on interventional pain management and supporting clinical locations, and former investment ProxsysRx provides pharmacy services to hospitals and health systems. Grouping all three simply as “technology” would obscure their different staffing, service-delivery, and operating requirements.
Sector-specialist private equity is therefore a useful secondary editorial classification, but it does not mean that every investment shares the same economics, operating playbook, or clinical exposure.
9. Where Does Fulcrum Equity Partners Invest?
Fulcrum is headquartered in Atlanta. The United States is the principal investment market represented in this profile. Headquarters and investment geography are separate facts: the reviewed companies span several states rather than being confined to Georgia.
Examples include FieldPulse in Dallas, MedScout in Austin, Worth in Orlando, Kevel in Durham, and Canvs AI in New York City. Pediatrics Plus adds an Arkansas-based healthcare platform to that footprint. These locations support a U.S.-oriented directory classification, although a selective portfolio is not a comprehensive geographic allocation analysis.
The North America geography group follows the headquarters and reviewed investment footprint. It should not be interpreted as proof of an equally weighted mandate across the United States, Canada, and Mexico, or as a contractual restriction against opportunities elsewhere.
Portfolio-company operations can also extend beyond an investee’s headquarters. Reflectiz’s financing announcement describes a Boston-based company with offices in Tel Aviv and Sydney. That establishes an international operating footprint at the company, not a separately verified regional fund strategy at Fulcrum.
The firm’s original formation city was not independently established, and older references to additional offices are not used here as proof of a complete current office network. The geographic interpretation is deliberately narrower: Atlanta headquarters, a reviewed U.S. investment footprint, and company-specific international operations where documented.
10. How Does Fulcrum Equity Partners Seek to Create Value?
Fulcrum describes its support model as combining capital with operating experience, executive recruitment, expansion planning, service partners, and connections among portfolio executives. Its approach includes recruiting at board and senior-leadership levels and bringing executives together through an annual retreat. These are firm-described resources, not independently proven results across the portfolio.
Its historical company case studies provide more specific examples. At Stratasan, Fulcrum describes constructing a board and introducing an individual with enterprise-sales experience to help develop the commercial approach. The case study also describes senior-leader sourcing and vendor introductions. This supports a firm-specific capability in management development and commercial support without establishing a uniform program deployed at every holding.
At Summit Spine & Joint Centers, Fulcrum describes helping recruit a chief compliance officer and physicians, assigning a team member to support new-location expansion, and establishing operational key performance indicators through the board. It also describes using its network to facilitate a payer relationship. These are reported initiatives at a named healthcare business, not a basis for attributing the same services or outcomes to every portfolio company.
The operating backgrounds of the principals help explain this positioning. Gardner built a sales-force development business, Greer founded a healthcare company, and Muir served as an operating executive before the fund organization developed. Those histories document experience; they do not prove that each investment receives the same level of operating intervention.
AI-enabled products at portfolio companies should also be distinguished from the manager’s capabilities. MedScout’s AI-agent launch establishes a company initiative. It does not, by itself, establish a dedicated Fulcrum AI team or a portfolio-wide AI transformation program.
11. What Types of Business Situations May Fit Fulcrum Equity Partners?
The following situations are analytical interpretations of Fulcrum’s documented strategy and transactions, not eligibility rules, investment advice, or evidence that the firm is currently seeking a particular opportunity.
- A software business needs expansion capital: MedScout’s financing supported product development and commercial expansion. A company with an established product and customers, but a need for additional resources to scale, is consistent with that example.
- A healthcare platform is expanding its services or locations: Pediatrics Plus’s partnership contemplated new markets and broader service offerings. This supports the relevance of healthcare businesses seeking growth without requiring founders to relinquish all ownership.
- A company needs acquisition funding or shareholder liquidity: These are expressly identified uses of capital in the Fund V strategy. The appropriate ownership structure would still depend on the individual transaction.
- An existing investment needs further capital: Fulcrum’s subsequent MedScout financing demonstrates the possibility of continued support rather than only a one-time initial investment.
- Management needs organizational support alongside financing: The Stratasan and Summit cases illustrate board development, leadership recruitment, commercial support, and expansion assistance.
The common thread is a growth objective connected to an operating business. Whether a specific company fits would require separate assessment of its economics, management, ownership needs, sector exposure, and transaction terms.
12. What Distinguishes Fulcrum Equity Partners?
Several documented characteristics help define Fulcrum’s investment proposition without implying superiority over other firms.
- Two connected sector pillars: The firm concentrates on B2B software and healthcare services, with healthcare information technology bridging those interests. Its company criteria differ between the software and healthcare service businesses.
- Ownership flexibility: Its published approach permits minority and majority growth investments. Pediatrics Plus provides a concrete example of a partnership in which founders retained substantial participation at the transaction announcement.
- Operating backgrounds among principals: The founders’ experience includes healthcare company leadership, software-related operations, finance, and sales-force development. This is part of the firm’s documented identity rather than an inferred operating capability.
- Entrepreneurs within the investor network: The 2024 Fund V announcement described more than 150 CEOs and leaders within the Fulcrum network alongside institutional investors. That is a dated description of the network, not a newly measured 2026 count.
- Potential continuity across financings: MedScout’s follow-on round and Summit’s historical transition between funds show different ways a relationship can extend beyond an initial transaction. Neither example establishes an automatic follow-on commitment for other companies.
Analytically, the combination is a sector-focused growth investor that can adapt ownership and support to the business situation. Its differentiators concern the model and resources, not verified investment returns.
13. How Should Fulcrum Equity Partners Be Understood Today?
As reviewed on October 13, 2026, Fulcrum is best understood as a growth equity firm centered on B2B software and healthcare services, with a sequential fund franchise and both minority and majority investment structures. Its current website continues to present those two sector pillars and five funds.
Recent documented investments show activity within that established model. MedScout announced a $10 million growth round led by Fulcrum on February 24, 2026. Worth reported the successful closing of a $30 million Series A round led by Fulcrum on March 24, 2026, with Amex Ventures and TTV Capital participating. These are company financing-round totals, not disclosed Fulcrum-only investment tickets.
The firm’s current portfolio interpretation must also account for exits. DriverReach and ProxsysRx are reported as former investments following their 2025 acquisitions, and Summit’s later exit is distinct from its earlier recapitalization between Fulcrum funds. Historical ownership percentages are not carried forward as current measurements in this profile.
Important limits remain. A dated current AUM measurement and a complete management-company ownership breakdown were not established. The portfolio table is selective, and fund associations are limited to those verified for its rows. The directory classification describes Fulcrum’s reviewed activities; it does not establish future investment appetite, company suitability, investment performance, or market leadership.
14. Frequently Asked Questions
Is Fulcrum Equity Partners a buyout firm or a venture capital firm?
Fulcrum describes itself as a growth equity firm and makes minority and majority investments. Its software activity includes venture-style financing rounds, while healthcare investments include operating service platforms. Growth equity / venture crossover is therefore the primary editorial classification.
Who founded Fulcrum Equity Partners?
Frank X. Dalton, Tom Greer, and Jeff Muir are identified as founders of the fund-based organization. Alston Gardner is also identified as a co-founder and operating partner, with a documented founding role at predecessor Fulcrum Ventures.
How much equity does Fulcrum typically invest?
Its published investment range is $5 million to $35 million of equity. That range should not be confused with enterprise value or a syndicated financing-round total, and it does not establish the amount invested in every individual company.
What is the most recent final fund close verified in this profile?
The most recent final close verified in this review is Fund V, announced on March 12, 2024, at $372 million. Its original $300 million target and $350 million hard cap were different measures from the completed closing amount.
Does Fulcrum require founders to sell their entire business?
No. Its model permits minority and majority investments. In the Pediatrics Plus partnership, the founders were described as continuing as the largest shareholders. That transaction demonstrates ownership flexibility without establishing identical terms for other businesses.
How does Fulcrum support portfolio companies beyond capital?
The firm describes executive recruitment, expansion planning, service-partner access, and executive networking. Its historical case studies also describe board development, commercial support, and healthcare expansion assistance. Those examples are not a guarantee of deployment or results at every holding.